New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
07:20 EDTICPTIntercept data should be positive catalyst for shares, says Oppenheimer
Oppenheimer predicts that top-line data for Intercept's Phase 2 FLINT study in NASH, expected to be released in July, will be a positive catalyst for the stock. The firm thinks that the risk/reward ratio for the stock heading into the data release should be attractive as long as expectations remain modest. It keeps a $499 price target and Outperform rating on the stock.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
10:00 EDTICPTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:35 EDTICPTIntercept upgraded at Nomura
Subscribe for More Information
July 29, 2014
18:35 EDTICPTOn The Fly: After Hours Movers
Subscribe for More Information
16:43 EDTICPTIntercept upgraded to Buy from Neutral at Nomura
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use